An overview of cancer treatment modalities

Z Abbas, S Rehman - Neoplasm, 2018 - books.google.com
Cancer is a global issue majorly affecting develo** countries. According to a survey, 63%
of deaths due to cancer are reported from develo** countries. There are different …

Regulating the human HECT E3 ligases

J Sluimer, B Distel - Cellular and molecular life sciences, 2018 - Springer
Ubiquitination, the covalent attachment of ubiquitin to proteins, by E3 ligases of the HECT
(homologous to E6AP C terminus) family is critical in controlling diverse physiological …

Structure-guided design and optimization of small molecules targeting the protein–protein interaction between the von Hippel–Lindau (VHL) E3 ubiquitin ligase and …

C Galdeano, MS Gadd, P Soares… - Journal of Medicinal …, 2014 - ACS Publications
E3 ubiquitin ligases are attractive targets in the ubiquitin–proteasome system, however, the
development of small-molecule ligands has been rewarded with limited success. The von …

Discovery and characterization of highly potent and selective allosteric USP7 inhibitors

G Gavory, CR O'Dowd, MD Helm, J Flasz… - Nature chemical …, 2018 - nature.com
Given the importance of ubiquitin-specific protease 7 (USP7) in oncogenic pathways,
identification of USP7 inhibitors has attracted considerable interest. Despite substantial …

Systematic approaches to identify E3 ligase substrates

M Iconomou, DN Saunders - Biochemical Journal, 2016 - portlandpress.com
Protein ubiquitylation is a widespread post-translational modification, regulating cellular
signalling with many outcomes, such as protein degradation, endocytosis, cell cycle …

[HTML][HTML] Targeting the ubiquitin-proteasome system for cancer therapeutics by small-molecule inhibitors

G LaPlante, W Zhang - Cancers, 2021 - mdpi.com
Simple Summary The ubiquitin-proteasome system regulates multiple facets of protein
homeostasis to modulate signal transduction in numerous biological processes. Not …

Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel–Lindau (VHL) E3 Ubiquitin Ligase: Structure–Activity Relationships Leading to the Chemical Probe (2S,4R …

P Soares, MS Gadd, J Frost, C Galdeano… - Journal of medicinal …, 2018 - ACS Publications
The von Hippel–Lindau tumor suppressor protein is the substrate binding subunit of the VHL
E3 ubiquitin ligase, which targets hydroxylated α subunit of hypoxia inducible factors (HIFs) …

System-wide modulation of HECT E3 ligases with selective ubiquitin variant probes

W Zhang, KP Wu, MA Sartori, HB Kamadurai… - Molecular cell, 2016 - cell.com
HECT-family E3 ligases ubiquitinate protein substrates to control virtually every eukaryotic
process and are misregulated in numerous diseases. Nonetheless, understanding of HECT …

Peptide and small molecule inhibitors of HECT-type ubiquitin ligases

T Mund, MJ Lewis, S Maslen, HR Pelham - Proceedings of the National …, 2014 - pnas.org
The human genome encodes several hundred E3 ubiquitin ligases containing RING
domains, and around 28 containing HECT domains. These enzymes catalyze the transfer of …

Speaking the host language: how Salmonella effector proteins manipulate the host

TD Pillay, SU Hettiarachchi, J Gan… - …, 2023 - microbiologyresearch.org
Salmonella injects over 40 virulence factors, termed effectors, into host cells to subvert
diverse host cellular processes. Of these 40 Salmonella effectors, at least 25 have been …